
Nasal steroids more effective than immunotherapy for rhinoconjunctivitis
NEW YORK (Reuters Health) – In a head-to-head comparison, nasal steroid therapy won out over short-course specific
NEW YORK (Reuters Health) – In a head-to-head comparison, nasal steroid therapy won out over short-course specific
By Melissa Schorr NEW YORK (Reuters Health) – New survey results suggest that 1 in 10 general
NEW YORK (Reuters Health) – Results of a small randomized trial show that the preventive use of
By Will Boggs, MD NEW YORK (Reuters Health) – The presence of cyclooxygenase 2 (COX-2)-positive T cells
By Robert Parsons GENEVA (Reuters Health) – The World Health Organisation's Executive Board on Friday passed a
הודעה ראשונה על רשימת התרופות והטכנולוגיות שיתווספו לסל הבריאות בשנת 2002 , דיווח מעתון הארץ למאמר בהארץ
By Richard Woodman LONDON (Reuters Health) – Fifty-seven people have died and nearly 7000 have reported suspected
By William Langbein NEW YORK (Reuters Health) – A two-year, online survey from a healthcare research group
By Peter Ramjug GAITHERSBURG, MD (Reuters) – A US advisory panel on Thursday backed GlaxoSmithKline Plc's Flovent
נא ציין כתובת דואר אלקטרוני שבה אתה מקבל דיוורי e-Med או זו שציינת בכרטיס האישי שלך.
קישור לאיפוס סיסמא נשלח למייל.
חזרה להתחברות